IART - Company ID 0000917520
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported net income of -$516.80M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$516.80M | -7389.9% |
| FY 2024 | -$6.90M | -110.2% |
| FY 2023 | $67.70M | -62.5% |
| FY 2022 | $180.60M | +6.8% |
| FY 2021 | $169.10M | +26.3% |
| FY 2020 | $133.89M | +166.7% |
| FY 2019 | $50.20M | -17.4% |
| FY 2018 | $60.80M | -6.1% |
| FY 2017 |
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported net income of -$516.80M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, INTEGRA LIFESCIENCES HOLDINGS CORP's net income declined from $27.99M to -$516.80M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $64.74M |
| -13.2% |
| FY 2016 | $74.56M | +2218.9% |
| FY 2015 | -$3.52M | -110.3% |
| FY 2014 | $34.00M | +261.4% |
| FY 2013 | -$21.07M | -151.1% |
| FY 2012 | $41.20M | +47.2% |
| FY 2011 | $27.99M | - |